Ethema Health Corp (GRST)

[Bubae]

They dropped the price to .0001 at the beginning of 2020 with note conversions where it stayed for 4 months. $1.3 billion shares with an average price of .0004. The reason that they didn't split then was because they started the year with only 155 million shares outstanding.

After closing the treatment center in January 2020 they then took on much more debt to start this new treatment center. The current story that is nearly 3 years old now has provided the narrative for the dilution to date and the price result. Now much of the debt in in default and the reg. "A" offering at .0012 isn't viable with the current narrative and share structure.



For the quarterly period ended March 31, 2020
https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&ref=115255536&type=HTML&symbol=GRST&companyName=Ethema+Health+Corp&formType=10-Q&formDescription=General+form+for+quarterly+reports+under+Section+13+or+15%28d%29&dateFiled=2020-09-28&CK=792935

12. Stockholders' deficit

a) Common shares
Authorized, issued and outstanding

The Company has authorized 10,000,000,000 shares with a par value of $0.01 per share. The company has issued and outstanding common shares of 1,577,862,975 and 155,483,897 as of March 31, 2020 and December 31, 2019, respectively.

Between January 6, 2020 and February 27, 2020, the Company issued 1,316,679,078 shares of common stock in terms of conversion notices received from convertible note holders. The shares issued were issued below par based on the market price of the stock on the date of conversion and were valued at $531,005.

Between January 6, 2020 and February 13, 2020, the Company issued 103,000,000 shares of common stock to Leonite Investment in terms of the exercise of 125,609,759 warrants valued at $92,952 at an average exercise price of 0.00009 per share, based on the price protection afforded to the warrant holder.

7. Short term convertible notes (continued)
Labrys Fund, LP

Between January 15, 2020 and February 25, 2020, in terms of conversion notices received, Labrys Fund LP converted the aggregate principal sum of $8,936 and interest of $19,867 into 479,160,076 shares of common stock at an average conversion price of 0.00006 per share.